Variant report
Variant | esv3439981 |
---|---|
Chromosome Location | chr5:97208021-97210794 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs34550006 | chr5:97209803-97209804 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs535133166 | chr5:97209808-97209809 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs74798440 | chr5:97209809-97209810 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs542153024 | chr5:97209817-97209818 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs554036934 | chr5:97209825-97209826 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs372834828 | chr5:97209829-97209830 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs571311191 | chr5:97209838-97209839 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs572600115 | chr5:97209848-97209849 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs12515542 | chr5:97209849-97209850 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs374079365 | chr5:97209854-97209855 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs532253835 | chr5:97209856-97209857 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs200122346 | chr5:97209857-97209858 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs543947905 | chr5:97209871-97209872 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs180918815 | chr5:97209873-97209874 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs529703148 | chr5:97209879-97209880 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs548548883 | chr5:97209886-97209887 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs544533780 | chr5:97209902-97209903 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs527551676 | chr5:97209912-97209913 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs561006943 | chr5:97209942-97209943 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs184936149 | chr5:97209950-97209951 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs144646933 | chr5:97210021-97210022 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs200591015 | chr5:97210024-97210025 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs570527685 | chr5:97210055-97210056 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs367968276 | chr5:97210056-97210057 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs542537665 | chr5:97210079-97210080 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs202238206 | chr5:97210080-97210081 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs5008866 | chr5:97210081-97210082 | Flanking Active TSS Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
28 | rs572918936 | chr5:97210095-97210096 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs556352782 | chr5:97210130-97210131 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs568371195 | chr5:97210134-97210135 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs535746734 | chr5:97210138-97210139 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs545113234 | chr5:97210165-97210166 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs191446718 | chr5:97210234-97210235 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs182776036 | chr5:97210258-97210259 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs72781545 | chr5:97210332-97210333 | Flanking Active TSS Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs563167239 | chr5:97210370-97210371 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs530061432 | chr5:97210381-97210382 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs544269957 | chr5:97210394-97210395 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs376361891 | chr5:97210442-97210443 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs186534367 | chr5:97210487-97210488 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs544382892 | chr5:97210586-97210587 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs191749673 | chr5:97210604-97210605 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs7720207 | chr5:97210613-97210614 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs182974175 | chr5:97210665-97210666 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs546608815 | chr5:97210694-97210695 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs146934483 | chr5:97210743-97210744 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs551907366 | chr5:97210755-97210756 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs137861552 | chr5:97210758-97210759 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs4628016 | chr5:97210779-97210780 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Cancer | 16751803 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Breast cancer | 17393978 | CNVD |
Cancer | 21359685 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
adenomatous polyposis | 22470819 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Lung cancer | 18438408 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Breast cancer | 21785460 | CNVD |
Merkel cell carcinoma | 19020549 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Testicular cancer | 18059402 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 16573809 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Mental retardation | 19471318 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Cancer | 20164920 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
abnormal development | 18461090 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Colorectal cancer | 16774939 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Breast cancer | 21611746 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:97209800-97210000 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
2 | chr5:97210000-97210400 | Flanking Active TSS | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
3 | chr5:97210000-97210400 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
4 | chr5:97210000-97210600 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
5 | chr5:97210000-97210600 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
6 | chr5:97210000-97210800 | Enhancers | Muscle Satellite Cultured Cells | -- |
7 | chr5:97210000-97210800 | Enhancers | NHDF-Ad | bronchial |
8 | chr5:97210200-97210600 | Enhancers | HSMMtube | muscle |
9 | chr5:97210400-97210800 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |